|
|
2700 BC |
Emperor Shen Nung's prescriptions (first published in Pen Tsao, the herbal of the Chinese pharmacopoeia, 1596) mentions the use of seaweed for the treatment of goiter |
300 BC |
Ayur Veda, Hindu holy text, discusses goiter. |
40 BC |
Pliny, Vitruvius, and Juvenal describe prevalence of goiter in the Alps and use of burnt seaweed for treatment. |
138 AD |
Greek physician, Soranus, mentions neck swelling following pregnancy |
340 |
Ko-Hung, Chinese alchemist, recommends seaweed for treatment of goiter among people living in mountains |
650 |
Sun Ssu-Mo, a Chinese physician, uses dried, powdered mollusc shells and chopped thyroid gland for the treatment of goiter |
961 |
Abul Kasim, personal physician to Caliph El-Hakin III of Codoba, is first to describe thyroidectomy for goiter and to perform a needle biopsy of the thyroid. |
1170 |
Roger of Salerno uses seaweed in the treatment of goiter |
1200 |
Arnaldus de Villanova reports that marine sponges could be used to treat goiters of recent origin in the young |
1475 |
Chinese physician, Wang Hei, recommends treatment of goiter with minced thyroid. |
1500 |
Leonardo da Vinci is first person to recognize and draw the thryoid gland |
1543 |
Andreas Vesalius provides first anatomic description and illustration of the thyroid gland |
1563 |
Eustachius introduces the term "isthmus" to describe tissue connecting the two lobes of the thyroid |
1602 |
Felix Platter gives first description of cretins (see 1754) found in Valais region of Switzerland. |
1656 |
Thomas Wharton names gland "thyroid" after the shape of an ancient Greecian shield |
1669 |
Albrecht van Haller describes constipation as a complication of cretinism |
1754 |
First use of the term "cretin" in the medical literature. The term is derived from the Latin "christianus" as affected individuals are incapable of committing a sin |
1789 |
F.E. Fodere suggests an association between goiter and cretinism |
1800 |
Guiseppe Frajani, personal physician to the Pope, described association of palpitations, goiter, and bulging of the eyes. This triad was known as Morbus Frajani. |
1811 |
Bernard Courtois discovers iodine by oxidizing burnt seaweed (i.e. kelp) with sulfuric acid |
1813 |
Gay-Lussac names the vapor discovered by Courtois iodine, from the Greek word for violet |
1818 |
Goiter reported in British Columbia |
1820 |
Jean Francois Coindet concludes that iodine deficiency causes goiter and begins treatment of goiter with iodine. |
1824 |
Alexander von Humboldt reports endemic goiter in Andes. He observes that goiter size decreases by 1/3 when an individual moves to an area where goiter is not endemic |
1825 |
C. Parry describes exophthalmic goiter |
1825 |
Boussingault detects iodine in the natural salt from mines in the northern Andes. Working in Bogota, he then recommends iodinated salt to prevent and treat endemic goiter |
1829 |
LGA Lugol recommends use of aqueous solution of iodine made from KI for treatment of scrofula (a neck mass from a goiter and cervical adenopathy due to tuberculosis and lymphoma were considered identical processes) |
1831 |
Francisco Freire-Allemao, a Brazilian physician, proposes iodine prophylaxis as a government-administered public health program, for goiter prevention. |
1834 |
Robert Graves describes a syndrome of palpitations, goiter, and exophthalmos in three women. |
1848 |
C. von Basedow describes exophthalmic goiter |
1849 |
J.L. Prevost adds iodine to food and water to prevent goiter |
1850 |
T.B. Curling describes cretinism with athyreosis |
1851 |
A. Chatin detects iodine in freshwater plants and recommends these as prophylaxis for endemic goiter based upon his theory that goiter is due to low little iodine in drinking water |
1857 |
B. Niepce describes enlargment of sella turcica in cretins with hypothyroidism in Switzerland |
1857 |
Maurice Schiff successfully performs total thyroidectomies in animals |
1860 |
R. Virchow suggests that cretinism and goiter are related |
1862 |
A. Trousseau introduces the term "Graves disease" |
1864 |
Baillarger reports occurrence of goiter in animals where goiter and cretinism are widespread |
1867 |
A. von Graefe describes lid lag in thyrotoxicosis (Basedow's disease) |
1873 |
Th. Billroth describes tetany following total thyroidectomy |
1877 |
William Gull publishes "On a Cretinoid State Supervening in Adult Life in Women" |
1882 |
William Ord coins term myxedema to describe middle aged women with cretinoid features |
1883 |
J.L. Reverdin describes cretinism following thryoidectomy. |
1883 |
Heinrich Bircher recognizes association of endemic goiter with geologic features characteristic of Quarternary glaciation |
1883 |
E.T. Kocher calls attention to myxedema following thyroidectomy. He was awarded the Nobel Prize in 1909 for his work on the thyroid gland. |
1886 |
Pierre Marie describes the characteristic tremor of hyperthyroidism |
1888 |
Rogowitsch observes pituitary hyperplasia in rabbits following thyroidectomy |
1891 |
F.D. von Recklinghausen reports on the occurrence of osteoporosis in hyperthyroidism |
1891 |
Victor Horsley, using monkeys, shows that myxedema, cretinism, and post-thyroidectomy cachexia are all due to a deficiency of thyroid function. |
1891 |
G.R. Murray introduces the use the thyroid extract to treat myxedema |
1895 |
Aldolf Magnus Levy describes the influence of the thyroid on the basal metabolic rate |
1896 |
E. Drechsel discovers first iodine-containing protein, "gorgonin", in the axial skeleton of coral. |
1896 |
Eugen Baumann discovers iodine as a natural constituent of the thyroid and names it "iodothyrin". |
1896 |
B. Riedel publishes first description of chronic, fibrous thyroiditis. |
1897 |
Pendred describes association of goiter with deaf-mutism. |
1898 |
W. Osler publishes case reports of sporadic cretinism, some of whom had a family history of goiter. |
1898 |
von Notthalt describes thryotoxicosis factitia and suggests that excess thyroid hormone produces Graves disease. |
1902 |
F. de Quervain describes subacute granulomatous thyroiditis |
1905 |
Robert Abbe treats Graves disease by implanting radium into the patient's goiter |
1907 |
H.L. Wheeler and G.S. Jamieson show that gorgonia, from coral, is diiodotyrosine. |
1907 |
David Marine publishes that iodine is necessary for thyroid function. |
1907 |
David Marine recommends treating Graves disease with iodine |
1910 |
Charles H. Mayo introduces term "hyperthyroidism" to describe the clinical conditions of primary exophthalmic goiter, toxic adenoma, and adenomatous goiter with hyperthyroidism. |
1911 |
D. Marine and C.H. Lenhart describe hyperthyroidism due to Graves disease and concomitant functioning thyroid |
1911 |
Henry Plummer from the Mayo Clinic distinguishes exophthalmic goiter from adenomatous goiter |
1912 |
Kocher coins term Jod Basedow for iodine overdosage. |
1912 |
J.F. Gudernatsch observes that thyroid extract has a specific effect on accelerating the differentiation (metamorphosis) in amphibian larva. |
1912 |
A. Seidell and F. Fenger describe the seasonal variation in thyroid iodine content. |
1913 |
Massachusetts General Hospital establishes Thyroid Unit under the direction of J.H. Means. |
1914 |
H. Hashimoto publishes 4 cases of a thyroid disorder characterized by a diffuse lymphocytic infiltration and fibrosis of the gland. |
1915 |
E.A. Kendall isolates thyroxine, a name he creates from a contraction of the term "thyroxindole". |
1916 |
Phillip E. Smith and Bennet M. Allen independently report that hypophysectomized tadpoles show thyroid involution and do not undergo metamorphosis. |
1916 |
H. Hunziker proposes that endemic goiter is due to regional iodine deficiency, which in turn was the result of abundent precipitation in the mountains and alluvial loss of soluble iodine salts. |
1917 |
M. Seymour in Boston reports on the use of x-rays to treat Graves disease. |
1917 |
thyroxine introduced into commercial distribution in the United States for $350 per gram. |
1920 |
Marine and Kimball successfully use iodine prophylaxis to prevent ovine and porcine athyreosis and trout goiter. |
1923 |
P.E. Smith and I.P. Smith show that bovine pituitary extracts could stimulate the thyroid of a hypopituitary tadpole. |
1924 |
H.S. Plummer at the Mayo Clinic report on the pre-operative use of iodine for the treatment of Graves disease. |
1924 |
George Hevesy introduces concept of radioactive tracers for the study of metabolic pathways. He receives Nobel Prize for this work in 1943. |
1926 |
McClendon reports that the iodine concentration in rainwater and in drinking water decreases as one travels from the Atlantic coast to the Great Lakes. |
1927 |
Harington determines chemical structure of thyroxine. |
1928 |
Harington and Barger synthesize thyroxine. |
1930 |
A. Chesney, T. Clawson, and B. Webster show that vegetables can cause goiter by showing that rabbits fed cabbage develop enlarged thyroids. |
1931 |
L. Loeb and R. Bassett extract and purify TSH from bovine pituitaries. |
1932 |
Naffziger introduces orbital decompression for the the treatment of exophthalmos. |
1935 |
Roy O. Greep demonstrates that pituitary TSH differs from LH and FSH. |
1936 |
Marine describes cyanide goiter. |
1936 |
Barker identifies goiter as a complication of thiocyanate treatment of hypertension. |
1941 |
J.H. Means and S. Hertz come up with the idea of using radioactive iodine to study thyroid physiology and pathology. |
1942 |
Radioactive iodine used for the treatment of Graves disease by Dr. S. Herz in Boston. |
1943 |
Kennedy observes that thiourea is goitrogenic |
1946 |
A. Astwood used thiourea and thiouracil for the medical treatment of Graves disease. |
1947 |
Cope, Rawson, and McArthur report first use of radioactive iodine to demonstrate a "hot" thyroid nodule |
1948 |
H. Pemberton sends letter to The Lancet describing his eponymous sign for a substernal goiter. |
1948 |
T. Tempka, J. Aleksandrowicz, M. Till publish the use of fine needle thyroid biopsy as a diagnostic method |
1949 |
R.G. Hoskins describes negative feedback of thyroid on pituritary, a mechanism which he termed "servo (feedback) mechanism". |
1949 |
J. Wolff and I. Chaikoff describe the regulatory effects of inorganic iodine on the thyroid. |
1949 |
Jones, Kornfeld, McLaughlin and Anderson synthesize methimazole. |
1950 |
J.B. Stanbury describes first case of a genetic abnormality of thyroid hormone synthesis. |
1951 |
B. Duffy and P. Fitzgerald call attention to thyroid cancer in children following head and neck irradiation. |
1952 |
Lawson, Rimington, and Searle synthesize carbimazole. |
1954 |
J. Gross and R. Pitt-Rivers isolate and synthesize T3. |
1954 |
J.B. Stanbury, J.B. Wyngaarden, and A. Godley describe use of perchlorate in treatment of hyperthyroidism. |
1954 |
J.B. Stanbury provides definitive proof of Jod Basedown in course of treating endemic goiter in Menduza, Argentena. |
1956 |
Goldschmidt, a Norweigen geochemist, identifies Quarternary glaciation as cause of iodine deficiency in soil. |
1956 |
Roitt and Doniach demonstrate autoantibodies in Hashimoto's disease. |
1959 |
J.B. Hazard, W.A. Hawk, and G. Crile identify medullary thyroid cancer as a distinct entity. |
1960 |
Adams, Purves, and McKenzie discover LATS in the serum of Graves disease patients. |
1963 |
D.H. Copp, A.G.F. Davidson, and B. A. Cheney provide first description of calcitonin. |
1965 |
S. Berson and R. Yalow develop radioimmunoassay procedure, and R. Yalow receives Nobel Prize for this work in 1977. |
1965 |
E.D. Williams reports 17 cases of cancer of the thyroid and pheochromocytoma. |
1966 |
R.F. Rohner, J.T. Prior, and J.H. Sipple describe the first cases of multiple endocrine neoplasia type 2. |
1969 |
Neonatal screening for congenital metabolic disease introduced in Switzerland. |
1970 |
A. Schally identifies TRH and receives Noble Prize for this work in 1977. |
1970 |
L. Braverman, S. Ingbar, and K. Sterling discover T4 to T3 conversion. |
1972 |
S. Berens, J. Wolff, D. Murphy show that the thyroid concentrates lithium. |
1974 |
S. Refetoff and L. DeGroot identify thyroid hormone resistance. |
1979 |
T.H. Liao and J. Pierce obtain first ultrapure TSH preparation and then demonstrate that TSH shares a common alpha subunit with LH and FSH. |
1998 |
Recombinant human TSH approved for clinical use in the United States |
Annual Meeting History of the American Thyroid Association (PDF File, 250 KB)
History of the International Thyroid Congress (PDF File, 159 KB)
Send in Additions to the Timeline:
Send in Additions to the Timeline: If you know of a thyroid related event that should be added to the ATA Thyroid Timeline or you have a comment about the ATA Thyroid Timeline please fill out the following survey.
Submit your historical articles, images and archival materials: Please send the ATA your pictures, papers, artifacts, and other materials relevant to the history of the thyroid for linking to the thyroid timeline. Timeline links to items which illustrate an event in thyroid history will also be implemented. You supply the item, and we'll take care of the rest. Please e-mail items to thyroid@thyroid.org
Thanks in Advance
